Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The combination therapy was effective and well-tolerated, especially in young patients.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Eight people with severe hair loss grew their hair back naturally.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.